Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.
about
RNA-seq reveals determinants of sensitivity to chemotherapy drugs in esophageal carcinoma cells.Recent advances of highly selective CDK4/6 inhibitors in breast cancerGenomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse.Recurrent amplification at 7q21.2 Targets CDK6 gene in primary myxofibrosarcomas and identifies CDK6 overexpression as an independent adverse prognosticator.The history and future of targeting cyclin-dependent kinases in cancer therapy.Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells.Targeting cell cycle and hormone receptor pathways in cancer.Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies.Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma.Basal progenitor cells bridge the development, malignant cancers, and multiple diseases of esophagus.Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease.Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index.Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.
P2860
Q33582964-A4A60125-3D8E-4CF7-B4BC-F4C3A352B048Q33602076-B60B5774-CEBA-403C-A33B-C8A700026FA9Q34190897-28ADB6AF-5EF3-4A46-890A-01B33348D5CCQ34220592-F61A7951-AF71-44E3-9C81-176941847CC1Q34460347-BA0E8364-3EBA-4BAE-A0DF-6F9189026FE4Q35666522-13771976-4BB0-4154-8157-4A7DC9F6E775Q36205151-908EAF03-D06E-4EDE-ADED-A7730675BFA8Q36521314-8AF1F7D3-E277-4EC3-9CE1-CA91884FDE50Q37502364-05A66F3C-C542-40CF-B75D-82D6D71429E3Q38369468-58EFE727-58FA-4E8B-B3D9-C11ABE9C51D3Q39183079-150422EE-5364-404D-A003-364F10696C92Q39636368-E3A0FF78-4D5F-4AB9-8B3B-C9EC5FA3A0BCQ42513257-932186EF-4A02-42B0-BBF6-640898647643Q45063614-F326CD66-B653-472E-AB57-300243E92672Q47142001-87890416-F37D-45CD-A09D-7601F5032E65Q47677607-88C0D83E-CE9A-4A1E-A119-641FFD8A063AQ48231208-CB518648-DE25-4157-A480-F60F23F0003E
P2860
Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Early G₁ cyclin-dependent kina ...... in esophageal adenocarcinoma.
@ast
Early G₁ cyclin-dependent kina ...... in esophageal adenocarcinoma.
@en
type
label
Early G₁ cyclin-dependent kina ...... in esophageal adenocarcinoma.
@ast
Early G₁ cyclin-dependent kina ...... in esophageal adenocarcinoma.
@en
prefLabel
Early G₁ cyclin-dependent kina ...... in esophageal adenocarcinoma.
@ast
Early G₁ cyclin-dependent kina ...... in esophageal adenocarcinoma.
@en
P2093
P2860
P50
P1476
Early G₁ cyclin-dependent kina ...... s in esophageal adenocarcinoma
@en
P2093
Amin Ismail
Arjun Pennathur
James D Luketich
Jeffrey H Peters
Liana Toia
Lincoln Stein
Marie Reveiller
Mary D'Souza
Santhoshi Bandla
William E Gooding
P2860
P304
P356
10.1158/1078-0432.CCR-11-0244
P407
P577
2011-05-18T00:00:00Z